The clinical name for what is commonly called Hashimoto's thyroiditis — the immune system attacking the thyroid, usually leading to an underactive gland. A 2026 meta-analysis of nearly 2.9 million genomes, covering five thyroid diseases at once, found hundreds of loci and real genetic overlap between this one and thyroid cancer.
Lymphocytic thyroiditis is the pathology term for chronic autoimmune inflammation of the thyroid gland, in which the immune system produces antibodies against the gland's own tissue. It is the most common cause of an underactive thyroid in places with enough dietary iodine, and is the disease most people know by its more familiar clinical name, Hashimoto's thyroiditis.
The study behind this page took an unusually broad approach: a meta-analysis of genome-wide association data from 19 biobanks, covering roughly 2.9 million genomes, analysing five thyroid diseases together rather than one at a time — thyroid cancer, benign nodular goiter, Graves' disease, lymphocytic thyroiditis, and primary hypothyroidism. Across all five combined, it found 313 previously known and 570 new independent genetic loci.
Analysing five diseases in one study let the researchers ask a question a single-disease GWAS cannot: how related are they, genetically? They found real genetic correlations between thyroid cancer, benign nodular goiter, and the autoimmune thyroid diseases (genetic correlation 0.16 to 0.97 depending on the pair) — meaning at least part of what predisposes someone to a benign thyroid nodule, or to autoimmune thyroid disease, overlaps with what predisposes to thyroid cancer itself. The study proposes a specific mechanism for part of this: genes involved in maintaining telomeres (the protective caps on chromosome ends) contribute to risk for both benign and malignant thyroid nodules, while genes involved in cell-cycle control and DNA repair and damage response were specifically tied to cancer risk rather than the benign conditions.
The study also built polygenic risk scores and tested them against real clinical outcomes in thyroid cancer patients — disease recurrence, tumour size, multifocality (more than one tumour), lymph node metastasis, and extension beyond the thyroid gland — and found genuine associations with several of these more aggressive features. In a biobank setting, these scores could identify individuals with aggressive thyroid cancer, which the authors frame as an opening for genetically informed population screening — a research finding, not a clinical tool available today.
This site already covers several angles on thyroid disease: hypothyroidism (the underactive state lymphocytic thyroiditis often causes), thyroid cancer, thyroid autoimmunity (TPO antibodies), and autoimmune thyroid disease (a narrower page built around a single 2012 study of the genetic overlap between Graves' disease and Hashimoto's specifically). This page holds the lymphocytic-thyroiditis arm of the much larger 2026 study described above — its own source, not yet folded into those other pages.
2026-07-29 · Nature Genetics
Largest Hashimoto's thyroiditis genetics study finds 19 new risk regions
A multi-ancestry meta-analysis of 48,694 people with Hashimoto's thyroiditis and 1,044,134 controls found 155 independent genetic associations, of which 45 variants across 19 loci had never been linked to hypothyroidism before. Functional analysis pointed at immune cells and the spleen specifically, underscoring T cells' role in the disease, supported by 161 significant links to gene-expression changes in immune cells and 40 in thyroid tissue itself. Six loci were specific to European-ancestry populations, highlighting real ancestry-specific genetic architecture alongside the shared signal. PMID:42527560.
Lymphocytic thyroiditis is diagnosed by thyroid antibody blood tests, thyroid function tests, and sometimes ultrasound — not by genotype. None of the variants on this page diagnose the condition or predict who will develop it; they describe part of the population-level genetic architecture behind it.
The genetic correlation this study found between lymphocytic thyroiditis and thyroid cancer is a population-level statistical relationship, not a statement that having one causes or guarantees the other — the large majority of people with autoimmune thyroid disease never develop thyroid cancer. The polygenic-risk-score findings for aggressive cancer features come from a research setting and are not a validated clinical screening tool.
What a 23andMe/AncestryDNA export or raw VCF can and can't tell you about Lymphocytic Thyroiditis (Hashimoto's) comes down to these specific, well-studied positions — not a diagnosis. 28 positions are linked to this page; the ones this page's own text discusses are shown first.
Databases, guidelines and references
Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.
Lymphocytic Thyroiditis (Hashimoto's). MyGeneLog™. https://www.mygenelog.com/conditions/lymphocytic-thyroiditis
The pathology term for chronic autoimmune inflammation of the thyroid gland, in which the immune system attacks the gland's own tissue. It is more commonly known by its clinical name, Hashimoto's thyroiditis, and is the most common cause of an underactive thyroid in iodine-sufficient regions.
A meta-analysis of genome-wide data from 19 biobanks (about 2.9 million genomes), covering five thyroid diseases together, found 313 known and 570 new genetic loci. It also found real genetic overlap between thyroid cancer, benign nodular goiter and the autoimmune thyroid diseases.
No. The study found a statistical genetic correlation between lymphocytic thyroiditis and thyroid cancer at a population level — most people with autoimmune thyroid disease never develop thyroid cancer, and this page's variants do not predict an individual's cancer risk.
No. Diagnosis relies on thyroid antibody blood tests, thyroid function tests, and sometimes ultrasound. These variants describe part of the population-level genetic architecture behind the disease, not a diagnostic tool.
Free to reuse. This page's text is original writing from freely-available research, licensed CC BY 4.0 — reuse it, including commercially, with attribution to MyGeneLog™. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.